Prime Medicine Inc (PRME)
3.345
-0.25
(-6.95%)
USD |
NASDAQ |
Nov 15, 16:00
3.34
0.00 (0.00%)
After-Hours: 20:00
Prime Medicine Revenue (Quarterly): 0.209M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 0.209M |
June 30, 2024 |
Date | Value |
---|---|
March 31, 2024 | 0.591M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.209M
Minimum
Sep 2024
0.591M
Maximum
Mar 2024
0.40M
Average
0.40M
Median
Revenue (Quarterly) Benchmarks
Bristol-Myers Squibb Co | 11.89B |
Molecular Templates Inc | 0.189M |
CEL-SCI Corp | -- |
AIM ImmunoTech Inc | 0.05M |
IGC Pharma Inc | 0.272M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -52.52M |
Total Expenses (Quarterly) | 54.44M |
EPS Diluted (Quarterly) | -0.44 |
Enterprise Value | 263.21M |
Profit Margin (Quarterly) | -25.13K% |
Earnings Yield | -61.58% |